Development and verification of an innovative medical compression stocking
| Reference number | |
| Coordinator | PRESSCISE AB |
| Funding from Vinnova | SEK 977 625 |
| Project duration | June 2018 - December 2020 |
| Status | Completed |
Important results from the project
The goal of the project was to develop and verify Lundatex® stocking (PressCise innovative compression stocking). The purpose of the new stocking was that it would increase patients´ quality of life and comfort, and at the same time provide a safer and better treatment, which is also more cost-effective than conventional stockings.
Expected long term effects
During the project, Lundatex® stocking was verified on patients with chronic leg edema, at Södra Älvsborgs Hospital. The study aimed to evaluate the stocking´s ability to reduce leg edema in comparison with regular treatment. Furthermore, perceived comfort, symptom relief and user-friendliness were evaluated. The preliminary results show that Lundatex® stocking can be a full-fledged, easier-to-use and more comfortable alternative to conventional stockings, while the price picture is lower.
Approach and implementation
During WP1, several prototypes of the stocking were developed, in parallel the clinical study was planned. The prototypes were first verified using technical tests. The study plan was completed and approved by the Ethics Review Committee. During WP2, the patient study was conducted at the same time as a business strategy was prepared. The project was severely delayed due to Corona´s outbreak. However, the study could be resumed and completed in the autumn of 2020.